99% Savings - Buy Just @1 Rs X
Triolmezest 20 Tablet is a commercial drug that is prescribed in the form of Tablet. Triolmezest 20 Tablet also has some secondary and off-label uses. These are listed below.
The correct dosage of Triolmezest 20 Tablet depends on the patient's age, gender, and medical history. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
The side effects typically associated with Triolmezest 20 Tablet include Upper respiratory tract infection. Besides the aforementioned side effects, there are other adverse effects of Triolmezest 20 Tablet as well, which are listed below. Usually, these side effects of Triolmezest 20 Tablet go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Triolmezest 20 Tablet has a Safe effect for pregnant women and Safe effect on lactating mothers. Further, the section on Triolmezest 20 Tablet related warnings talks about Triolmezest 20 Tablet's effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Bradycardia (Slow Heart Rate), Low Blood Pressure (Hypotension), Low Blood Pressure (Hypotension) must refrain from the use of Triolmezest 20 Tablet since this can cause severe adverse effects. Some other conditions that can be affected by Triolmezest 20 Tablet are listed in the contraindications section below.
Drug reaction of Triolmezest 20 Tablet with other medicines has been reported. Refer to the list below for further details.
You should also be aware that Triolmezest 20 Tablet is not safe while driving, and is not addiction.
Triolmezest 20 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Triolmezest 20 Tablet safe for pregnant women?
Triolmezest is safe for pregnant women.
Is the use of Triolmezest 20 Tablet safe during breastfeeding?
Triolmezest is safe for breastfeeding women.
What is the effect of Triolmezest 20 Tablet on the Kidneys?
Triolmezest may have mild side effects on the kidneys.
What is the effect of Triolmezest 20 Tablet on the Liver?
Triolmezest has very mild side effects on the liver.
What is the effect of Triolmezest 20 Tablet on the Heart?
Triolmezest is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Triolmezest 20 Tablet unless your doctor advises you to do so -
Is this Triolmezest 20 Tablet habit forming or addictive?
Forming a habit of Triolmezest 20 Tablet has not been reported.
Interaction between Food and Triolmezest 20 Tablet
Taking Triolmezest 20 Tablet with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Triolmezest 20 Tablet
Taking alcohol with Triolmezest 20 Tablet can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvasc® (amlodipine besylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 540, 549, 550
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 147-148
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hydrochlorothiazide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 582-586
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448